Stay updated on Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Sign up to get notified when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.

Latest updates to the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.2%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check28 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
- Check35 days agoChange DetectedThe web page has been updated to version 2.16.8, and the HHS Vulnerability Disclosure section has been added.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.1%
- Check50 days agoChange DetectedA service alert has been added indicating planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.9%
Stay in the know with updates to Clinical Trial: INO-3112 & Durvalumab for HPV Cancers
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: INO-3112 & Durvalumab for HPV Cancers page.